+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Actinium-225 Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6141844
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Actinium-225 is catalyzing a shift in the targeted radiopharmaceutical therapies market by unlocking new levels of precision and efficacy for advanced oncology care. Senior leaders in biopharma, healthcare delivery, and supply chain sectors are closely monitoring these developments for the competitive and clinical advantages they create.

Market Snapshot: Actinium-225 and Targeted Radiopharmaceutical Progress

The Actinium-225 market is witnessing accelerated growth, driven by its superior alpha-emitting properties and compelling results in precision oncology. Recent improvements in chelation chemistry and targeted delivery vehicles have addressed initial hurdles around in vivo stability and minimized off-target toxicity. The momentum is reinforced by emerging clinical evidence, favorable safety profiles in early trials, and a maturing regulatory environment. Manufacturing scalability and clarity from regulatory bodies are further supporting mainstream adoption as development networks strengthen globally.

Scope & Segmentation

This report provides a detailed analysis, focusing on the following segmentation dimensions to inform strategic decision-making:

  • Indication: Neuroendocrine tumors, prostate cancer
  • Product Type: Antibody conjugates (including bispecific and monoclonal antibodies), peptide conjugates, small molecule conjugates
  • End User: Private hospitals, public hospitals, research institutes, specialty clinics
  • Distribution Channel: Direct sales, national distributors, regional distributors, online pharmacies
  • Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe/Middle East/Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Orano Med SAS, Nordion (Canada) Inc., ITM Isotope Technologies Munich SE, Curium Pharma SAS, Eckert & Ziegler Radiopharma GmbH, Jubilant Radiopharma Services Inc., Advanced Accelerator Applications S.A., RayzeBio, Inc., Actinium Pharmaceuticals, Inc., JSC Isotope

Key Takeaways for Decision Makers

  • Actinium-225’s high linear energy transfer makes it uniquely capable of causing lethal double-strand DNA breaks within targeted malignant cells, with minimized impact to healthy tissues.
  • The market is transitioning from early-stage experimental approaches to real-world clinical application, as advances in conjugation techniques and delivery platforms reach translational stages.
  • Collaborative networks among contract development organizations, academia, and government agencies are improving scalability and regulatory clarity, which strengthens commercialization pathways.
  • Differentiated adoption patterns are observed across indications, with neuroendocrine and prostate cancers leading early demand, while diverse product modalities allow flexible targeting for varying patient populations.
  • Distribution models are segmenting toward high-volume direct sales, specialized distributor networks, and burgeoning online pharmacy channels to support growing clinical integration.

Tariff Impact on Actinium-225 Supply Chain

In 2025, U.S. tariffs on critical raw materials, reagents, and isotope transport have raised costs within the Actinium-225 supply chain. Suppliers and distributors are adapting by optimizing vendor portfolios and expanding domestic production. Downstream, clinical research investments are being recalibrated in response to higher procurement expenses, with sponsors turning to strategic procurement partnerships and integrated logistics solutions. While near-term cost inflation is felt across the sector, these shifts are expected to catalyze long-term resilience through infrastructure investment and supply chain optimization.

SEO Focus: Actinium-225 in Precision Oncology

Stakeholders seeking competitive positioning in the Actinium-225 segment benefit from the alignment of next-generation conjugation chemistries, regulatory policy refinement, and strategic alliances. As antibody-based, peptide, and small-molecule platforms each demonstrate unique efficacy, technology use is evolving rapidly, supported by improvements in isotope purification and carrier design. Geographically, advanced networks in the Americas are propelling early adoption, while collaborative development in Europe, the Middle East, Africa, and Asia-Pacific is enhancing regional capacity and market access strategies.

Methodology & Data Sources

This analysis relies on a dual approach: confidential primary interviews with radiopharmaceutical executives, clinical investigators, and supply chain experts provide qualitative insights, while secondary research incorporates published literature, regulatory submissions, and industry reports. Triangulation of data from these sources, paired with validation workshops, ensures thorough and accurate perspective on market trends.

Why This Report Matters

  • Senior stakeholders gain clarity on evolving Actinium-225 segment dynamics to inform resource allocation and partnership strategies.
  • Comprehensive coverage of product modalities, regions, and distribution channels enables differentiation in go-to-market planning.
  • Actionable insights on tariff impacts and supply chain resilience support risk management and investment prioritization.

Conclusion

The Actinium-225 market is at a pivotal juncture as technological advances, regulatory evolution, and industry collaboration collectively drive its integration into oncology practice. Accessing this report provides senior leaders with the foresight needed to navigate and shape the next generation of targeted radiopharmaceutical therapies.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid expansion of global actinium-225 supply through innovative generator technologies and partnerships
5.2. Clinical milestones in targeted alpha therapies using actinium-225 conjugates for prostate cancer treatment
5.3. Strategic collaborations accelerating scalable manufacturing of actinium-225 for radiopharmaceutical pipelines
5.4. Emerging regulatory frameworks shaping global approval pathways for actinium-225 based therapeutics
5.5. Development of next generation bifunctional chelators optimizing actinium-225 stability and delivery in vivo
5.6. Advances in patient selection algorithms utilizing AI to enhance efficacy of actinium-225 targeted treatments
5.7. Cost pressure and reimbursement strategies influencing commercialization of actinium-225 radioligand therapies
5.8. Expansion of actinium-225 research into neuroendocrine and hematologic malignancies beyond prostate applications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Actinium-225 Market, by Indication
8.1. Introduction
8.2. Neuroendocrine Tumors
8.3. Prostate Cancer
9. Actinium-225 Market, by Product Type
9.1. Introduction
9.2. Antibody Conjugates
9.2.1. Bispecific Antibodies
9.2.2. Monoclonal Antibodies
9.3. Peptide Conjugates
9.4. Small Molecule Conjugates
10. Actinium-225 Market, by End User
10.1. Introduction
10.2. Hospital
10.2.1. Private Hospital
10.2.2. Public Hospital
10.3. Research Institute
10.4. Specialty Clinic
11. Actinium-225 Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributor
11.3.1. National Distributor
11.3.2. Regional Distributor
11.4. Online Pharmacy
12. Americas Actinium-225 Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Actinium-225 Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Actinium-225 Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Orano Med SAS
15.3.2. Nordion (Canada) Inc.
15.3.3. ITM Isotope Technologies Munich SE
15.3.4. Curium Pharma SAS
15.3.5. Eckert & Ziegler Radiopharma GmbH
15.3.6. Jubilant Radiopharma Services Inc.
15.3.7. Advanced Accelerator Applications S.A.
15.3.8. RayzeBio, Inc.
15.3.9. Actinium Pharmaceuticals, Inc.
15.3.10. JSC Isotope
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. ACTINIUM-225 MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ACTINIUM-225 MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ACTINIUM-225 MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ACTINIUM-225 MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ACTINIUM-225 MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACTINIUM-225 MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACTINIUM-225 MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ACTINIUM-225 MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ACTINIUM-225 MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ACTINIUM-225 MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ACTINIUM-225 MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ACTINIUM-225 MARKET: RESEARCHAI
FIGURE 24. ACTINIUM-225 MARKET: RESEARCHSTATISTICS
FIGURE 25. ACTINIUM-225 MARKET: RESEARCHCONTACTS
FIGURE 26. ACTINIUM-225 MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ACTINIUM-225 MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACTINIUM-225 MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ACTINIUM-225 MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ACTINIUM-225 MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ACTINIUM-225 MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ACTINIUM-225 MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ACTINIUM-225 MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ACTINIUM-225 MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ACTINIUM-225 MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ACTINIUM-225 MARKET SIZE, BY BISPECIFIC ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ACTINIUM-225 MARKET SIZE, BY BISPECIFIC ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ACTINIUM-225 MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ACTINIUM-225 MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ACTINIUM-225 MARKET SIZE, BY PEPTIDE CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ACTINIUM-225 MARKET SIZE, BY PEPTIDE CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ACTINIUM-225 MARKET SIZE, BY SMALL MOLECULE CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ACTINIUM-225 MARKET SIZE, BY SMALL MOLECULE CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ACTINIUM-225 MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ACTINIUM-225 MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ACTINIUM-225 MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ACTINIUM-225 MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ACTINIUM-225 MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ACTINIUM-225 MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ACTINIUM-225 MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ACTINIUM-225 MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ACTINIUM-225 MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ACTINIUM-225 MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ACTINIUM-225 MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ACTINIUM-225 MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ACTINIUM-225 MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ACTINIUM-225 MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ACTINIUM-225 MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ACTINIUM-225 MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ACTINIUM-225 MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ACTINIUM-225 MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ACTINIUM-225 MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ACTINIUM-225 MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 90. CANADA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 91. CANADA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 94. CANADA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 95. CANADA ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 98. CANADA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 99. CANADA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. CANADA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. CANADA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 102. CANADA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 103. MEXICO ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 109. MEXICO ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ACTINIUM-225 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 175. GERMANY ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. GERMANY ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. GERMANY ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. GERMANY ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 180. GERMANY ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 181. GERMANY ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. GERMANY ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. GERMANY ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 184. GERMANY ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 185. GERMANY ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. GERMANY ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. GERMANY ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 188. GERMANY ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 189. FRANCE ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. FRANCE ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. FRANCE ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. FRANCE ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. FRANCE ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 194. FRANCE ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 195. FRANCE ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. FRANCE ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. FRANCE ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 198. FRANCE ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 199. FRANCE ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. FRANCE ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. FRANCE ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 202. FRANCE ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 217. ITALY ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. ITALY ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. ITALY ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. ITALY ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. ITALY ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 222. ITALY ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 223. ITALY ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ITALY ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ITALY ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 226. ITALY ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 227. ITALY ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. ITALY ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ITALY ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 230. ITALY ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 231. SPAIN ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. SPAIN ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. SPAIN ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. SPAIN ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. SPAIN ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 236. SPAIN ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 237. SPAIN ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SPAIN ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SPAIN ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 240. SPAIN ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 241. SPAIN ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. SPAIN ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SPAIN ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 244. SPAIN ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 287. DENMARK ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. DENMARK ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. DENMARK ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. DENMARK ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. DENMARK ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 292. DENMARK ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 293. DENMARK ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. DENMARK ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. DENMARK ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 296. DENMARK ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 297. DENMARK ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. DENMARK ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. DENMARK ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 300. DENMARK ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 315. QATAR ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. QATAR ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. QATAR ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. QATAR ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. QATAR ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 320. QATAR ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 321. QATAR ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. QATAR ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. QATAR ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 324. QATAR ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 325. QATAR ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. QATAR ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. QATAR ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 328. QATAR ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 329. FINLAND ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 330. FINLAND ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 331. FINLAND ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. FINLAND ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. FINLAND ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 334. FINLAND ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 335. FINLAND ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. FINLAND ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. FINLAND ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 338. FINLAND ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 339. FINLAND ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. FINLAND ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. FINLAND ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 342. FINLAND ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. SWEDEN ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. SWEDEN ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 352. SWEDEN ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 353. SWEDEN ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. SWEDEN ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. SWEDEN ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 356. SWEDEN ACTINIUM-225 MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 357. NIGERIA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 358. NIGERIA ACTINIUM-225 MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 359. NIGERIA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 360. NIGERIA ACTINIUM-225 MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 361. NIGERIA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2018-2024 (USD MILLION)
TABLE 362. NIGERIA ACTINIUM-225 MARKET SIZE, BY ANTIBODY CONJUGATES, 2025-2030 (USD MILLION)
TABLE 363. NIGERIA ACTINIUM-225 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 364. NIGERIA ACTINIUM-225 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 365. NIGERIA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 366. NIGERIA ACTINIUM-225 MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 367. NIGERIA ACTINIUM-225 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Actinium-225 Market report include:
  • Orano Med SAS
  • Nordion (Canada) Inc.
  • ITM Isotope Technologies Munich SE
  • Curium Pharma SAS
  • Eckert & Ziegler Radiopharma GmbH
  • Jubilant Radiopharma Services Inc.
  • Advanced Accelerator Applications S.A.
  • RayzeBio, Inc.
  • Actinium Pharmaceuticals, Inc.
  • JSC Isotope